Apella Capital, LLC Novo Nordisk A S Transaction History

Apella Capital, LLC

  • $2.54 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024
SELL
$122.71 - $146.91 $24,787 - $29,675
-202 Reduced 9.07%
2,025 $289,000
Q1 2024

Apr 10, 2024
BUY
$102.11 - $135.92 $23,689 - $31,533
232 Added 11.63%
2,227 $285,000
Q4 2023

Jan 05, 2024
BUY
$87.78 - $105.45 $175,121 - $210,372
1,995 New
1,995 $206,000

Others Institutions Holding NVO

# of Institutions
1,870
Shares Held
318M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $186B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Apella Capital, LLC Portfolio

Follow Apella Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email